Pharmacology of anticoagulants used in the treatment of venous thromboembolism

Anticoagulant drugs are the foundation of therapy for patients with VTE. While effective therapeutic agents, anticoagulants can also result in hemorrhage and other side effects. Thus, anticoagulant therapy selection should be guided by the risks, benefits and pharmacologic characteristics of each ag...

Descripción completa

Detalles Bibliográficos
Autores principales: Nutescu, Edith A., Burnett, Allison, Fanikos, John, Spinler, Sarah, Wittkowsky, Ann
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4715843/
https://www.ncbi.nlm.nih.gov/pubmed/26780737
http://dx.doi.org/10.1007/s11239-015-1314-3
_version_ 1782410487698292736
author Nutescu, Edith A.
Burnett, Allison
Fanikos, John
Spinler, Sarah
Wittkowsky, Ann
author_facet Nutescu, Edith A.
Burnett, Allison
Fanikos, John
Spinler, Sarah
Wittkowsky, Ann
author_sort Nutescu, Edith A.
collection PubMed
description Anticoagulant drugs are the foundation of therapy for patients with VTE. While effective therapeutic agents, anticoagulants can also result in hemorrhage and other side effects. Thus, anticoagulant therapy selection should be guided by the risks, benefits and pharmacologic characteristics of each agent for each patient. Safe use of anticoagulants requires not only an in-depth knowledge of their pharmacologic properties but also a comprehensive approach to patient management and education. This paper will summarize the key pharmacologic properties of the anticoagulant agents used in the treatment of patients with VTE.
format Online
Article
Text
id pubmed-4715843
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-47158432016-01-22 Pharmacology of anticoagulants used in the treatment of venous thromboembolism Nutescu, Edith A. Burnett, Allison Fanikos, John Spinler, Sarah Wittkowsky, Ann J Thromb Thrombolysis Article Anticoagulant drugs are the foundation of therapy for patients with VTE. While effective therapeutic agents, anticoagulants can also result in hemorrhage and other side effects. Thus, anticoagulant therapy selection should be guided by the risks, benefits and pharmacologic characteristics of each agent for each patient. Safe use of anticoagulants requires not only an in-depth knowledge of their pharmacologic properties but also a comprehensive approach to patient management and education. This paper will summarize the key pharmacologic properties of the anticoagulant agents used in the treatment of patients with VTE. Springer US 2016-01-16 2016 /pmc/articles/PMC4715843/ /pubmed/26780737 http://dx.doi.org/10.1007/s11239-015-1314-3 Text en © The Author(s) 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Article
Nutescu, Edith A.
Burnett, Allison
Fanikos, John
Spinler, Sarah
Wittkowsky, Ann
Pharmacology of anticoagulants used in the treatment of venous thromboembolism
title Pharmacology of anticoagulants used in the treatment of venous thromboembolism
title_full Pharmacology of anticoagulants used in the treatment of venous thromboembolism
title_fullStr Pharmacology of anticoagulants used in the treatment of venous thromboembolism
title_full_unstemmed Pharmacology of anticoagulants used in the treatment of venous thromboembolism
title_short Pharmacology of anticoagulants used in the treatment of venous thromboembolism
title_sort pharmacology of anticoagulants used in the treatment of venous thromboembolism
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4715843/
https://www.ncbi.nlm.nih.gov/pubmed/26780737
http://dx.doi.org/10.1007/s11239-015-1314-3
work_keys_str_mv AT nutescueditha pharmacologyofanticoagulantsusedinthetreatmentofvenousthromboembolism
AT burnettallison pharmacologyofanticoagulantsusedinthetreatmentofvenousthromboembolism
AT fanikosjohn pharmacologyofanticoagulantsusedinthetreatmentofvenousthromboembolism
AT spinlersarah pharmacologyofanticoagulantsusedinthetreatmentofvenousthromboembolism
AT wittkowskyann pharmacologyofanticoagulantsusedinthetreatmentofvenousthromboembolism

Ejemplares similares